0001671858-18-000001.txt : 20180108 0001671858-18-000001.hdr.sgml : 20180108 20180108165859 ACCESSION NUMBER: 0001671858-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180108 DATE AS OF CHANGE: 20180108 EFFECTIVENESS DATE: 20180108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Silverback Therapeutics, Inc. CENTRAL INDEX KEY: 0001671858 IRS NUMBER: 811489190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-302681 FILM NUMBER: 18517012 BUSINESS ADDRESS: STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-456-2900 MAIL ADDRESS: STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98109 D 1 primary_doc.xml X0708 D LIVE 0001671858 Silverback Therapeutics, Inc. 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA WASHINGTON 98109 206-456-2900 DELAWARE None None Corporation true 2016 Peter A. Thompson 500 Fairview Avenue North, Ste 600 Seattle WA WASHINGTON 98109 Executive Officer Director Robert Hershberg 500 Fairview Avenue North, Ste 600 Seattle WA WASHINGTON 98109 Director Saqib Islam 500 Fairview Avenue North, Ste 600 Seattle WA WASHINGTON 98109 Director Biotechnology Decline to Disclose 06b false 2017-12-22 true true true false 0 3749 3749 0 false 1 0 0 0 false Silverback Therapeutics, Inc. Jill E. Fishbein Jill E. Fishbein Secretary 2018-01-08